Your browser doesn't support javascript.
loading
Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial.
Majem, Margarita; Goldman, Jonathan W; John, Thomas; Grohe, Christian; Laktionov, Konstantin; Kim, Sang-We; Kato, Terufumi; Vu, Huu Vinh; Lu, Shun; Li, Shanqing; Lee, Kye Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Atagi, Shinji; Zeng, Lingmin; Kulkarni, Dakshayini; Medic, Nenad; Tsuboi, Masahiro; Herbst, Roy S; Wu, Yi-Long.
Affiliation
  • Majem M; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Goldman JW; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California.
  • John T; Department of Medical Oncology, Austin Health, Melbourne, Victoria, Australia.
  • Grohe C; Klinik für Pneumologie-Evangelische Lungenklinik Berlin Buch, Berlin, Germany.
  • Laktionov K; Federal State Budgetary Institution "N.N.Blokhin National Medical Research Center of Oncology" of the Ministry of Health of the Russian Federation (N.N. Blokhin NMRCO), Moscow, Russia.
  • Kim SW; Department of Oncology, Asan Medical Center, Seoul, South Korea.
  • Kato T; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Vu HV; Department of Thoracic Surgery, Choray Hospital, Ho Chi Minh City, Vietnam.
  • Lu S; Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Li S; Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
  • Lee KY; Precision Medicine Lung Cancer Center, Konkuk University Medical Center, Seoul, Republic of Korea.
  • Akewanlop C; Division of Medical Oncology, Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand.
  • Yu CJ; Department of Internal Medicine, National Taiwan University Hospital Hsinchu Branch and National Taiwan University College of Medicine, Taipei, Taiwan.
  • de Marinis F; Thoracic Oncology Division, European Institute of Oncology (IEO), IRCCS, Milan, Italy.
  • Bonanno L; Medical Oncology 2, Istituto Oncologico Veneto (IOV), IRCCS, Padua, Italy.
  • Domine M; Department of Oncology, Hospital Universitario Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain.
  • Shepherd FA; Department of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Center and the University of Toronto, Toronto, Ontario, Canada.
  • Atagi S; Department of Thoracic Oncology, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.
  • Zeng L; Late Oncology Statistics, AstraZeneca, Gaithersburg, Maryland.
  • Kulkarni D; Late Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
  • Medic N; AstraZeneca Oncology Business Unit, Academy House, Cambridge, United Kingdom.
  • Tsuboi M; Department of Thoracic Surgery and Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Herbst RS; Medical Oncology, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut.
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.
Clin Cancer Res ; 28(11): 2286-2296, 2022 06 01.
Article in En | MEDLINE | ID: mdl-35012927
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Small Cell Lung Carcinoma / Lung Neoplasms Type of study: Clinical_trials / Guideline Aspects: Patient_preference Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Small Cell Lung Carcinoma / Lung Neoplasms Type of study: Clinical_trials / Guideline Aspects: Patient_preference Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication: